Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page adds guidance and join-related sections to assist potential participants, and updates the recruitment status; it also includes a formatting tweak to the Intervention/Treatment header and updates the site revision to v3.6.0.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page's revision label has changed from v3.5.4 to v3.5.5, indicating a small internal update to the revision history. No substantive content or data on the page appears to be affected.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows a new revision tag (v3.5.4) indicating a newer build. This is a metadata update and does not change visible content or how the page functions.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s interface/version indicator was incremented from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site update rather than a change to the study record.SummaryDifference0.0%

- Check66 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.